Pyxis Oncology is based in Cambridge, Massachusetts. It has raised $326M in total funding. Latest round: IPO.
Pyxis Oncology funding overview
Pyxis Oncology is based in Cambridge, Massachusetts. Pyxis Oncology has raised $326M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in January 2021. The round record for Pyxis Oncology runs through 2021; nothing later has been disclosed. Investors on record include Longwood Fund, Leaps by Bayer, Arix Bioscience, RTW Investments, LP, Perceptive Advisors, RA Capital Management and 1 others. 7 distinct backers are named across the disclosed rounds.
Pyxis Oncology at a glance
Total raised
$326M
Latest round
IPO
Latest round date
January 2021
Headquarters
Cambridge, Massachusetts
Notable investors
Longwood Fund, Leaps by Bayer, Arix Bioscience, RTW Investments, LP, Perceptive Advisors, RA Capital Management, Pfizer Ventures
Frequently asked about Pyxis Oncology funding
How much has Pyxis Oncology raised?
Pyxis Oncology has raised $326M in total disclosed funding across the rounds on record.
Who has invested in Pyxis Oncology?
Longwood Fund, Leaps by Bayer, Arix Bioscience, RTW Investments, LP, Perceptive Advisors, RA Capital Management are named among the investors backing Pyxis Oncology.
What was the latest Pyxis Oncology funding round?
The most recent disclosed round is an IPO, announced in January 2021.
Where is Pyxis Oncology based?
Pyxis Oncology is based in Cambridge, Massachusetts.
When did Pyxis Oncology last raise?
The last disclosed Pyxis Oncology round closed in January 2021 at IPO.
We update the Pyxis Oncology record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
